Alivus Life Sciences Limited has informed the Exchange about Schedule of Investors/Analyst Meeting.

Board & Shareholder Meetings View source PDF

ALIVUS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-0.2%1-day move

₹1062.00

prior close

₹1066.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.0+1.0+1.0+0.7-0.2-2.2+0.0+2.5+1.0-1.3-3.8+2.4+7.3—

Up moveDown movePending

AI summary

Alivus Life Sciences Limited (formerly Glenmark Life Sciences Limited) has disclosed a scheduled one-on-one virtual meeting with institutional investor Karma Capital on May 22, 2026. The disclosure is made under Regulation 30 and Para A of Part A of Schedule III of SEBI LODR Regulations, 2015. The company notes that the schedule and mode of meeting may change due to exigencies. This is a routine regulatory intimation and does not contain any material business or financial updates.

Likely market impact

This is a standard procedural filing with no material impact on the stock. It reflects routine investor engagement activity and does not signal any new developments or changes in company fundamentals.